Open, Online Database Of Clinical Trials Planned

open trials

A newly announced project will create an open, online database of information about the clinical research trials worldwide. The initiative, called Open Trials, will be directed by Ben Goldacre, an internationally known author (“Bad Science”) and advocated for clinical transparency. As announced by Open Knowledge yesterday, Open Trials “will aggregate information from a wide variety […]

WHO Reviews Its Essential Medicines List; Some New Candidates Under Patent

essential meds

The World Health Organization is reviewing its list of essential medicines this week. Over 70 candidate medicines are expected to be assessed by an Expert Committee. Some of those medicines are under patent and highly priced, which poses an accessibility challenge.

WHO Opens Its Database Of Medicines Side Effects To The Public

safe medicines

The World Health Organization has announced that its Global Medicines Safety Database is now open to the general public. The database named VigiAccess can now be accessed on any computer or smartphone in the world.

Clinical Trial Transparency, Medicines Access On Agendas Today

Gilead Solvaldi tablet

The World Health Organization today issued a call for disclosure of results from clinical trials for medical products, no matter what the results of the trials were. And a variety of events and publications are addressing medicines access today.

WHO Issues Guideline For Manufacturers Of Generic Hepatitis C Medicine

Medicines - Flickr - Doug88888

The World Health Organization has issued a guidance document on the design of bioequivalence studies for a leading hepatitis C medicine. Generic drug companies seeking prequalification by the WHO need to demonstrate that their generic version is equivalent to the originator drug.

Gathering Looks At Governance Of WIPO, IP Governance In Multilateral Fora

ICTSD event image Mar 2015

On 5 March, the International Centre for Trade and Sustainable Development (ICTSD) in collaboration with Oxford University’s Global Economic Governance Programme (GEG) hosted an event in Geneva to discuss challenges and issues in intellectual property governance.

Global Fund Publishes Terms Of Reference Of Equitable Access Initiative

Global Fund

An initiative spearheaded by the Global Fund for AIDS, Tuberculosis and Malaria to ensure equitable access to medicines in particular in middle-income countries now has a dedicated webpage publishing the terms of reference of the initiative. Also available is the list of high-level participants who attended the first meeting of the initiative held last week.

Why The Request By Least Developed Countries For An Extension Of The Transitional Period For Granting And Enforcing Medicines Patents Needs To Be Supported

Ellen 't Hoen

Ellen ‘t Hoen writes: On 24 February 2015 Bangladesh on behalf of the 34 Least Developed Country members (LDCs) of the World Trade Organization (WTO) submitted a request for an extension of the transitional period under article 66.1 TRIPS with respect to pharmaceutical products until the country is no longer classified as LDC.[1] The original extension, set to expire on 1st January 2016, specifically removes the obligation for LDCs to comply with Section 5 (Patents) and Section 7 (Protection of Undisclosed Information) of Part II of TRIPS, including any obligation to enforce rights under these provisions.

It is a little known fact that since the adoption of the 2001 Doha Declaration on TRIPS and Public Health, LDCs have frequently used the extension in day-to-day procurement of low cost generic medicines, in particular to access medicines needed for the treatment of HIV.

New Quiet Initiative To Improve Drug Access In Middle-Income Countries, Change Country Classification System

developing country crowd image

This week a confidential high-level expert meeting was convened in Geneva to start work on a potential change in the country classification used by global health actors to remedy the growing problem of access to medicines in middle-income countries.

Medicines Patent Pool Nails Down Another Key Paediatric Drug

www.photovalet.com

The Medicines Patent Pool today announced it has struck a licence with MSD, the North American-based Merck pharmaceutical company, to boost access to and innovation on raltegravir, a child-approved HIV medicine. The outcome is particularly significant because it opens options for very young children.